1. HBW Insight
  2. >>Geography
  3. >>Europe

Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care

 
• By Eileen Francis

In this episode of HBW Insight's Over The Counter podcast, we connect with Neil D’Souza, CEO of Makersite GmbH, a data software company based in Stuttgart, Germany that offers “next generation” product data management tools that help personal care and other industries manage product sustainability, cost and compliance.

HBW Over The Counter Podcast
• Source: Citeline Design Team

Eighty percent of a product’s environmental impact is determined at the design phase. As laws are enacted at the federal state, and local levels to implement extended producer responsibility takeback programs, companies are pressed now more than ever to find ways to reduce packaging and incorporate bio-based packaging materials.

In this episode of HBW’s Over The Counter podcast, we connect with Neil D’Souza, CEO of Makersite GmbH, a data software company based in Stuttgart, Germany.

D’Souza spoke about the ways in which AI and other technologies are used to improve packaging design, the challenges and questions all companies face in creating a more sustainable product and opportunities in the area of reusable/refillable design.

Open Media

Guest Bio

Neil D'Souza
• Source: Neil D'Souza

Neil D’Souza, CEO Of Makersite GmbH, worked for 20 years in academia in the area of climate science before he committed himself to helping industry make better, more sustainable products. His firm offers digital tools that help companies manage cost, environment, compliance and risk data.

More from Europe

‘The Only Certainty Is Uncertainty’ In The UK’s Consumer Health Market

 
• By David Ridley

While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.

Over The Counter: Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls

 
• By David Ridley

HBW Insight catches up with PAGB CEO Michelle Riddalls to chat about the association's new five year plan. Riddalls also reflects on the successes of the last five years, including relaunching the UK Reclassification Alliance, which has published a list of Rx-to-OTC switches the government would like to see applications for. Part one of two.

AESGP: ‘No Evidence’ Of Antimicrobial Resistance With OTC Antifungals Or Antivirals

 
• By David Ridley

Two AESGP papers reviewing the evidence for AMR risk associated with a range of OTC antifungals and antivirals conclude there is litte to no risk associated with the responsible self-care use of such medicines.

Over The Counter: What To Expect From The 61st AESGP Annual Meeting, With Jurate Švarcaite

 
• By David Ridley

HBW Insight speaks to AESGP director general Jurate Švarcaite about what's on the agenda for the upcoming 61st AESGP Annual Meeting, which will take place in Warsaw, Poland, between 2-4 June. Highlights include the role of prevention in self-care, discussions about how regulators will ensure the competitiveness of European industry on the world stage and incoming changes to sustainability legislation.

More from Leadership

People On The Move: Appointments At PAGB, Activ’Inside, EMA

 
• By Tom Gallen

Round up of the latest appointments: PAGB names vice presidents; Activ'Inside gets first US head; EMA elects management board chair.

Will Martin Makary Bring Calm To US FDA As Commissioner During Turbulent Times?

 
• By Sarah Karlin-Smith

Stakeholders are pleading for newly confirmed FDA Commissioner Martin Makary to stand up for the agency's high scientific standards and staff as he begins his term.

US FDA Under Makary: MAHA With A Lighter Touch

 
• By Michael McCaughan

US FDA Commissioner nominee Martin Makary is being embraced by industry, and Senate Democrats, as a more traditional pick than other Trump Administration nominees, but the Make America Healthy Again agenda still is clearly coming to the agency.